(S)-1-((S)-3-(4-溴噻唑-2-基)-2-((1S,2S)-2-甲基环丙烷-1-甲酰胺)丙酰基)六氢哒嗪-3-甲酸甲酯

RMC-6236/Daraxonrasib intermediate (CAS No. 3060084-27-4) is a key pharmaceutical intermediate for the synthesis of KRAS-targeted anticancer drugs, with molecular formula C17H23BrN4O4S and molecular weight about 459.4. This compound is an advanced pharmaceutical intermediate used in the synthesis of kras-targeted anticancer drugs, including covalent inhibitors developed for the treatment of solid tumors such as non-small cell lung cancer and colorectal cancer.. This product is suitable for laboratory research, analytical method development, and quality control applications. Our company, located in Hangzhou and Hubei, China, supplies this compound with guaranteed purity of 98% and offers standard packaging of 1 g, 5 g and 10 g to meet different customer requirements. The minimum order quantity is 100 mg. We are committed to providing high-quality products, competitive pricing, timely delivery and professional technical support. For detailed specifications, certificates of analysis and bulk quotations, please feel free to contact us.